Literature DB >> 19838863

Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Valerie Voon1, Brady Reynolds, Christina Brezing, Cecile Gallea, Meliha Skaljic, Vindhya Ekanayake, Hubert Fernandez, Marc N Potenza, Raymond J Dolan, Mark Hallett.   

Abstract

RATIONALE: Dopaminergic medication-related impulse control disorders (ICDs) such as pathological gambling and compulsive shopping have been reported in Parkinson's disease (PD). HYPOTHESIS: We hypothesized that dopamine agonists (DAs) would be associated with greater impulsive choice or greater discounting of delayed rewards in PD patients with ICDs (PDI).
METHODS: Fourteen PDI patients, 14 PD controls without ICDs, and 16 medication-free matched normal controls were tested on the Experiential Discounting Task (EDT), a feedback-based intertemporal choice task, spatial working memory, and attentional set shifting. The EDT was used to assess choice impulsivity (hyperbolic K value), reaction time (RT), and decision conflict RT (the RT difference between high conflict and low conflict choices). PDI patients and PD controls were tested on and off DA.
RESULTS: On the EDT, there was a group by medication interaction effect [F(1,26) = 5.62; p = 0.03] with pairwise analyses demonstrating that DA status was associated with increased impulsive choice in PDI patients (p = 0.02) but not in PD controls (p = 0.37). PDI patients also had faster RT compared to PD controls [F(1,26) = 7.51, p = 0.01]. DA status was associated with shorter RT [F(3,24) = 8.39, p = 0.001] and decision conflict RT [F(1,26) = 6.16, p = 0.02] in PDI patients but not in PD controls. There were no correlations between different measures of impulsivity. PDI patients on DA had greater spatial working memory impairments compared to PD controls on DA (t = 2.13, df = 26, p = 0.04).
CONCLUSION: Greater impulsive choice, faster RT, faster decision conflict RT, and executive dysfunction may contribute to ICDs in PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838863      PMCID: PMC3676926          DOI: 10.1007/s00213-009-1697-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  72 in total

1.  Effects of chronic cocaine on impulsivity: relation to cortical serotonin mechanisms.

Authors:  Tracie A Paine; Hans C Dringenberg; Mary C Olmstead
Journal:  Behav Brain Res       Date:  2003-12-17       Impact factor: 3.332

2.  Working memory and the mind.

Authors:  P S Goldman-Rakic
Journal:  Sci Am       Date:  1992-09       Impact factor: 2.142

Review 3.  A review of delay-discounting research with humans: relations to drug use and gambling.

Authors:  Brady Reynolds
Journal:  Behav Pharmacol       Date:  2006-12       Impact factor: 2.293

4.  Impact of strain and D-amphetamine on impulsivity (delay discounting) in inbred mice.

Authors:  Christa M Helms; Jamie M Reeves; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

5.  Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats.

Authors:  J B Richards; K E Sabol; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

6.  The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats.

Authors:  T Koskinen; S Ruotsalainen; J Sirviö
Journal:  Pharmacol Biochem Behav       Date:  2000-08       Impact factor: 3.533

7.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

8.  Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats.

Authors:  Jennifer L Perry; Erin B Larson; Jonathan P German; Gregory J Madden; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  High impulsivity predicts the switch to compulsive cocaine-taking.

Authors:  David Belin; Adam C Mar; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  Science       Date:  2008-06-06       Impact factor: 47.728

10.  Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay-discounting task.

Authors:  Jessica J Stanis; Randi M Burns; Luke K Sherrill; Joshua M Gulley
Journal:  Drug Alcohol Depend       Date:  2008-06-09       Impact factor: 4.492

View more
  88 in total

Review 1.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

2.  Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Authors:  Patrick S Johnson; Gregory J Madden; Jeffrey S Stein
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-30       Impact factor: 3.157

Review 3.  Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 4.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

Review 5.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

6.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.

Authors:  I Boileau; D Payer; B Chugani; D S S Lobo; S Houle; A A Wilson; J Warsh; S J Kish; M Zack
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

7.  The Neuropsychopharmacology of Pathological Gambling.

Authors:  Kourosh Zakeri; Marc N Potenza
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

8.  Test-retest reliability and construct validity of the Experiential Discounting Task.

Authors:  Rochelle R Smits; Jeffrey S Stein; Patrick S Johnson; Amy L Odum; Gregory J Madden
Journal:  Exp Clin Psychopharmacol       Date:  2013-02-18       Impact factor: 3.157

9.  Jumping to conclusions in untreated patients with Parkinson's disease.

Authors:  Flavio Henrique de Rezende Costa; Bruno Averbeck; Sean S O'Sullivan; Maurice Borges Vincent; Ana Lucia Rosso; Andrew J Lees; Atbin Djamshidian
Journal:  Neuropsychologia       Date:  2016-03-05       Impact factor: 3.139

Review 10.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.